vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Douglas Elliman Inc. (DOUG). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $245.4M, roughly 1.2× Douglas Elliman Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 27.9%, a 68.4% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 0.9%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 10.7%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Douglas Elliman Inc. is a leading U.S.-based residential real estate brokerage firm. It offers luxury property sales, rentals, property management, and advisory solutions, serving high-net-worth clients across key metro markets including New York, California, Florida, and Texas.
ACAD vs DOUG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $245.4M |
| Net Profit | $273.6M | $68.6M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 27.3% |
| Net Margin | 96.3% | 27.9% |
| Revenue YoY | 9.4% | 0.9% |
| Net Profit YoY | 90.3% | 1243.4% |
| EPS (diluted) | $1.61 | $0.80 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $245.4M | ||
| Q3 25 | $278.6M | $262.8M | ||
| Q2 25 | $264.6M | $271.4M | ||
| Q1 25 | $244.3M | $253.4M | ||
| Q4 24 | $259.6M | $243.3M | ||
| Q3 24 | $250.4M | $266.3M | ||
| Q2 24 | $242.0M | $285.8M | ||
| Q1 24 | $205.8M | $200.2M |
| Q4 25 | $273.6M | $68.6M | ||
| Q3 25 | $71.8M | $-24.7M | ||
| Q2 25 | $26.7M | $-22.7M | ||
| Q1 25 | $19.0M | $-6.0M | ||
| Q4 24 | $143.7M | $-6.0M | ||
| Q3 24 | $32.8M | $-27.2M | ||
| Q2 24 | $33.4M | $-1.7M | ||
| Q1 24 | $16.6M | $-41.5M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | 27.3% | ||
| Q3 25 | 12.8% | -4.1% | ||
| Q2 25 | 12.2% | -2.0% | ||
| Q1 25 | 7.9% | -2.1% | ||
| Q4 24 | 59.1% | -6.7% | ||
| Q3 24 | 12.6% | -2.8% | ||
| Q2 24 | 12.6% | -1.3% | ||
| Q1 24 | 7.4% | -20.7% |
| Q4 25 | 96.3% | 27.9% | ||
| Q3 25 | 25.8% | -9.4% | ||
| Q2 25 | 10.1% | -8.4% | ||
| Q1 25 | 7.8% | -2.4% | ||
| Q4 24 | 55.4% | -2.5% | ||
| Q3 24 | 13.1% | -10.2% | ||
| Q2 24 | 13.8% | -0.6% | ||
| Q1 24 | 8.0% | -20.7% |
| Q4 25 | $1.61 | $0.80 | ||
| Q3 25 | $0.42 | $-0.29 | ||
| Q2 25 | $0.16 | $-0.27 | ||
| Q1 25 | $0.11 | $-0.07 | ||
| Q4 24 | $0.86 | $-0.06 | ||
| Q3 24 | $0.20 | $-0.33 | ||
| Q2 24 | $0.20 | $-0.02 | ||
| Q1 24 | $0.10 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $115.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $183.9M |
| Total Assets | $1.6B | $444.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $115.5M | ||
| Q3 25 | $258.0M | $143.0M | ||
| Q2 25 | $253.6M | $136.3M | ||
| Q1 25 | $217.7M | $136.8M | ||
| Q4 24 | $319.6M | $145.5M | ||
| Q3 24 | $155.1M | $151.4M | ||
| Q2 24 | $177.1M | $92.9M | ||
| Q1 24 | $204.7M | $91.5M |
| Q4 25 | $1.2B | $183.9M | ||
| Q3 25 | $917.3M | $115.1M | ||
| Q2 25 | $822.4M | $137.6M | ||
| Q1 25 | $765.2M | $158.2M | ||
| Q4 24 | $732.8M | $162.2M | ||
| Q3 24 | $577.2M | $173.6M | ||
| Q2 24 | $516.7M | $196.9M | ||
| Q1 24 | $464.0M | $195.1M |
| Q4 25 | $1.6B | $444.4M | ||
| Q3 25 | $1.3B | $480.6M | ||
| Q2 25 | $1.2B | $489.0M | ||
| Q1 25 | $1.1B | $493.9M | ||
| Q4 24 | $1.2B | $493.9M | ||
| Q3 24 | $976.9M | $502.7M | ||
| Q2 24 | $914.1M | $463.9M | ||
| Q1 24 | $855.1M | $461.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $-14.4M |
| Free Cash FlowOCF − Capex | — | $-14.7M |
| FCF MarginFCF / Revenue | — | -6.0% |
| Capex IntensityCapex / Revenue | — | 0.1% |
| Cash ConversionOCF / Net Profit | -0.18× | -0.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-17.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $-14.4M | ||
| Q3 25 | $74.3M | $5.5M | ||
| Q2 25 | $64.0M | $642.0K | ||
| Q1 25 | $20.3M | $-5.6M | ||
| Q4 24 | $40.4M | $-9.0M | ||
| Q3 24 | $63.2M | $9.0M | ||
| Q2 24 | $25.0M | $1.3M | ||
| Q1 24 | $29.1M | $-27.3M |
| Q4 25 | — | $-14.7M | ||
| Q3 25 | $73.9M | $4.7M | ||
| Q2 25 | — | $-575.0K | ||
| Q1 25 | — | $-6.7M | ||
| Q4 24 | — | $-10.2M | ||
| Q3 24 | $63.2M | $7.7M | ||
| Q2 24 | — | $432.0K | ||
| Q1 24 | — | $-29.4M |
| Q4 25 | — | -6.0% | ||
| Q3 25 | 26.5% | 1.8% | ||
| Q2 25 | — | -0.2% | ||
| Q1 25 | — | -2.6% | ||
| Q4 24 | — | -4.2% | ||
| Q3 24 | 25.2% | 2.9% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | -14.7% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | 0.1% | 0.3% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | 0.0% | 0.5% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | -0.18× | -0.21× | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | — | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
DOUG
| Commissions And Other Brokerage Income | $240.3M | 98% |
| Property Management Income | $2.8M | 1% |
| Property Management | $2.2M | 1% |
